Procedures and Therapeutics

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.
He discusses how gastroenterologists can resume semi-elective and elective endoscopies by following key guidelines to protect patients and staff against COVID-19.
In an interview with Gastroenterology Consultant, Mark Gromski, MD, discussed the importance of the FDA’s recent clearance of the first disposable duodenoscope and how the clearance can impact clinical practice.
Walter Chan, MD, MPH, and Nayna Lodhia, MD, both from Brigham and Women’s Hospital, answer our questions about their research on the role of defecation dysfunction and rectal sensitivity in opioid-related chronic constipation.
Mark Gromski, MD, from the Indiana University School of Medicine, answers our questions about his research that compared the efficacy of reprocessing duodenoscopes with double high-level disinfection vs liquid chemical sterilization in endoscopic retrograde cholangiopancreatography.
Jessica R. Allegretti, MD, MPH, answers our questions about her study on the impact of fecal microbiota transplant from lean donors on metabolically normal people with obesity.

Gil Melmed, MD, from Cedars-Sinai Medical Center in Los Angeles, California, talks about what constitutes a good quality report following a colonoscopy on a patient with inflammatory bowel disease.

Russell Cohen, MD, director of the Inflammatory Bowel Disease Center at UChicago Medicine, discusses using biologic agents to treat patients with Crohn disease and ulcerative colitis.

Hans Herfarth, MD, professor of medicine at the University of North Carolina, discusses the primary indication for the use of methotrexate — in the treatment of patients with Crohn disease who are

Marla Dubinsky, MD, division chief of pediatric gastroenterology and nutrition and codirector of the Susan and Leonard Feinstein IBD Clinical Center at the Icahn School of Medicine at Mt.

Raymond Cross, MD, director of the Inflammatory Bowel Disease program at the University of Maryland School of Medicine, discussed the positioning and uses of 5-ASAs and corticosteroids in the treat

Michele Rubin, APN, of UChicago Medicine, discusses the importance of finding the right drug for each patient as part of the move toward personalized medicine.